601P The prognostic role of longitudinal assessment of plasma androgen receptor (AR) copy number (CN) in metastatic castration-resistant prostate cancer (mCRPC): Analysis from a prospective biomarkers trial. - Brighi, N.; Conteduca, V.; Gurioli, G.; Scarpi, E.; Lolli, C.; Schepisi, G.; Casadei, C.; Bleve, S.; Ulivi, P.; De Giorgi, U. (Annals of Oncology, 2021)